Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 July 2009, doi:10.1136/bmj.b3044
Cite this as: BMJ 2009;339:b3044
| The first 150 words of the full text of this article appear below. |
Ehlers and colleagues conclude from their long term modelling study that screening men aged 65 for abdominal aortic aneurysm is not cost effective.1 This conclusion conflicts with that of the 10 year follow-up of the randomised Multicentre Aneurysm Screening Study (MASS),2 our detailed long term modelling based on individual patient data in MASS,3 4 and other recent modelling studies.
To try to understand the reasons for the difference, we substituted the unit costs and parameter estimates provided by Ehlers into our model based on MASS. Although the cost per quality adjusted life year (QALY) increased from our original estimate of £3000 to around £6000, it does not begin to approach their figure of £43 000. So there must be other explanations, such as the structure or assumptions of their model, which cannot be investigated without further information from the authors.5
Their cost effectiveness estimate is implausible. From observed data in MASS,
Simon Thompson, director1, Lois Kim, lecturer2, Lu Gao, statistician1
1 MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 0SR, 2 London School of Hygiene and Tropical Medicine, London WC1E 7HT
simon.thompson@mrc-bsu.cam.ac.uk